Trial Profile
A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fixed combination beclomethasone dipropionate 100 microg plus formoterol fumarate 6 microg/actuation pMDI with HFA-134a propellant (Foster) versus standard salbutamol pMDI 100 microg/actuation (Ventolin Evohaler) therapy in asthmatic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2012
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms MART-1
- Sponsors Chiesi
- 02 Aug 2011 New trial record